{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:04:29Z","timestamp":1786986269981,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0506200"],"award-info":[{"award-number":["2017YFA0506200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21S11900100"],"award-info":[{"award-number":["21S11900100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["20210104"],"award-info":[{"award-number":["20210104"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900157"],"award-info":[{"award-number":["81900157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073292"],"award-info":[{"award-number":["82073292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102756"],"award-info":[{"award-number":["82102756"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130075"],"award-info":[{"award-number":["82130075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["21SG18"],"award-info":[{"award-number":["21SG18"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.celrep.2022.110622","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:13:38Z","timestamp":1649808818000},"page":"110622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Repurposing antiparasitic antimonials to noncovalently rescue temperature-sensitive p53 mutations"],"prefix":"10.1016","volume":"39","author":[{"given":"Yigang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huien","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8708-9711","authenticated-orcid":false,"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6902-3751","authenticated-orcid":false,"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.110622_bib1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/cdd.2016.48","article-title":"Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth","volume":"23","author":"Aggarwal","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2022.110622_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature14430","article-title":"Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment","volume":"523","author":"Alexandrova","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110622_bib3","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.1073\/pnas.1105028108","article-title":"Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration","volume":"108","author":"Arbely","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A."},{"key":"10.1016\/j.celrep.2022.110622_bib4","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1002\/anie.201601091","article-title":"Targeted covalent inhibitors for drug design","volume":"55","author":"Baillie","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.celrep.2022.110622_bib5","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.celrep.2022.110622_bib6","doi-asserted-by":"crossref","first-page":"E5271","DOI":"10.1073\/pnas.1610421113","article-title":"2-Sulfonylpyrimidines: mild alkylating agents with anticancer activity toward p53-compromised cells","volume":"113","author":"Bauer","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A."},{"key":"10.1016\/j.celrep.2022.110622_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.aax3649","article-title":"A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies","volume":"365","author":"Boettcher","year":"2019","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.celrep.2022.110622_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/35094077","article-title":"Rescuing the function of mutant p53","volume":"1","author":"Bullock","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2022.110622_bib9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.onc.1203434","article-title":"Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy","volume":"19","author":"Bullock","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2022.110622_bib10","series-title":"The Chemistry of Arsenic, Antimony and Bismuth. Biological Chemistry of Arsenic, Antimony and Bismuth","first-page":"1","author":"Burford","year":"2010"},{"key":"10.1016\/j.celrep.2022.110622_bib11","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1038\/sj.onc.1208419","article-title":"PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis","volume":"24","author":"Bykov","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2022.110622_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0302-282","article-title":"Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound","volume":"8","author":"Bykov","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.110622_bib13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110622_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2022.110622_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"Chakravarty","year":"2017","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.celrep.2022.110622_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.celrep.2022.110622_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2020.11.013","article-title":"Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2022.110622_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.8023157","article-title":"Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations","volume":"265","author":"Cho","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.110622_bib19","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1200\/JCO.20.02342","article-title":"Eprenetapopt plus azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a phase II study by the Groupe Francophone des My\u00e9lodysplasies (GFM)","volume":"39","author":"Cluzeau","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2022.110622_bib20","series-title":"Encyclopedia of Ocean Sciences","first-page":"1737","article-title":"Metalloids and oxyanions","author":"Cutter","year":"2001"},{"key":"10.1016\/j.celrep.2022.110622_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc.2017.36","article-title":"Drugging the 'undruggable' cancer targets","volume":"17","author":"Dang","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2022.110622_bib22","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1074\/jbc.M109.083469","article-title":"SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53","volume":"285","author":"Demma","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2022.110622_bib23","first-page":"15","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.celrep.2022.110622_bib24","doi-asserted-by":"crossref","first-page":"LB006","DOI":"10.1158\/1538-7445.AM2021-LB006","article-title":"Abstract LB006: PC14586: the first orally bioavailable small molecule reactivator of Y220C mutant p53 in clinical development","volume":"81","author":"Dumble","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2022.110622_bib25","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. Section D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2022.110622_bib26","first-page":"2782","article-title":"GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data","volume":"28","author":"Feng","year":"2012","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.celrep.2022.110622_bib27","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2022.110622_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12551-013-0134-y","article-title":"Antimony transport mechanisms in resistant leishmania parasites","volume":"6","author":"Fr\u00e9zard","year":"2014","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.celrep.2022.110622_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1039\/c2mt00176d","article-title":"Greater binding affinity of trivalent antimony to a CCCH zinc finger domain compared to a CCHC domain of kinetoplastid proteins","volume":"4","author":"Fr\u00e9zard","year":"2012","journal-title":"Metallomics"},{"key":"10.1016\/j.celrep.2022.110622_bib30","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/MCB.21.5.1874-1887.2001","article-title":"A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain","volume":"21","author":"Gaiddon","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2022.110622_bib31","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.celrep.2022.110622_bib32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/cmdc.201900107","article-title":"Covalent inhibition in drug discovery","volume":"14","author":"Ghosh","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.celrep.2022.110622_bib33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","article-title":"Mutational processes shape the landscape of TP53 mutations in human cancer","volume":"50","author":"Giacomelli","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2022.110622_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41568-021-00337-1","article-title":"ATO stabilizes structural p53 mutants","volume":"21","author":"Gummlich","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2022.110622_bib35","article-title":"Integrated analysis of multimodal single-cell data","author":"Hao","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2022.110622_bib36","first-page":"1879","article-title":"A temperature sensitive mutant of the human p53, Val138, arrests rat cell growth without induced expression of cip1\/waf1\/sdi1 after temperature shift-down","volume":"10","author":"Hirano","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2022.110622_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.110622_bib38","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3892\/ijo.2012.1520","article-title":"Transactivation and reactivation capabilities of temperature-dependent p53 mutants in yeast and human cells","volume":"41","author":"Jagosova","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.celrep.2022.110622_bib39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1016251023427","article-title":"Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis","volume":"12","author":"Jaser","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.celrep.2022.110622_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D","article-title":"Screening the p53 status of human cell lines using a yeast functional assay","volume":"19","author":"Jia","year":"1997","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.celrep.2022.110622_bib41","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1073\/pnas.0607286103","article-title":"Structural basis for understanding oncogenic p53 mutations and designing rescue drugs","volume":"103","author":"Joerger","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A."},{"key":"10.1016\/j.celrep.2022.110622_bib42","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/sj.onc.1210291","article-title":"Structure-function-rescue: the diverse nature of common p53 cancer mutants","volume":"26","author":"Joerger","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2022.110622_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","article-title":"The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches","volume":"85","author":"Joerger","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.celrep.2022.110622_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol Crystallogr."},{"key":"10.1016\/j.celrep.2022.110622_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110622_bib46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.molcel.2018.06.012","article-title":"A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation","volume":"71","author":"Kotler","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2022.110622_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front Immunol."},{"key":"10.1016\/j.celrep.2022.110622_bib48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ccr.2009.03.003","article-title":"PRIMA-1 reactivates mutant p53 by covalent binding to the core domain","volume":"15","author":"Lambert","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2022.110622_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"Cancer. p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110622_bib50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2012.10.022","article-title":"Cell-type, dose, and mutation-type specificity dictate mutant p53 functions in\u00a0vivo","volume":"22","author":"Lee","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2022.110622_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-cancerbio-030518-055455","article-title":"Targeting therapies for the p53 protein in cancer treatments","volume":"3","author":"Levine","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.celrep.2022.110622_bib52","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/cdd.2011.71","article-title":"SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis","volume":"18","author":"Li","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2022.110622_bib53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ccell.2021.01.012","article-title":"Arsenic and an old place: rescuing p53 mutants in cancer","volume":"39","author":"Loh","year":"2021","journal-title":"Cancer cell"},{"key":"10.1016\/j.celrep.2022.110622_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet. J."},{"key":"10.1016\/j.celrep.2022.110622_bib55","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Mart\u00ednez-Jim\u00e9nez","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2022.110622_bib56","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.celrep.2022.110622_bib57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2641","article-title":"p53 mutations in cancer","volume":"15","author":"Muller","year":"2013","journal-title":"Nat. Cel. Biol."},{"key":"10.1016\/j.celrep.2022.110622_bib58","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: new functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2022.110622_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110622_bib60","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1107\/S0907444903008126","article-title":"A graphical user interface to the CCP4 program suite","volume":"59","author":"Potterton","year":"2003","journal-title":"Acta Crystallogr. Section D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2022.110622_bib61","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/537S63a","article-title":"Perspective: the precision-oncology illusion","volume":"537","author":"Prasad","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110622_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2022.110622_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others","volume":"15","author":"Sabapathy","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2022.110622_bib64","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0959-8049(16)32638-7","article-title":"COTI-2, a new anticancer drug currently under clinical investigation, targets mutant p53 and negatively modulates the PI3K\/AKT\/mTOR pathway","volume":"69","author":"Salim","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.celrep.2022.110622_bib65","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.20.02341","article-title":"Eprenetapopt (APR-246) and azacitidine in TP53-mutant myelodysplastic syndromes","volume":"39","author":"Sallman","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2022.110622_bib66","doi-asserted-by":"crossref","first-page":"TPS2613","DOI":"10.1200\/jco.2015.33.15_suppl.tps2613","article-title":"A phase 1, dose-escalation, safety, pharmacokinetic, pharmacodynamic study of thioureidobutyronitrile, a novel p53 targeted therapy, in patients with advanced solid tumors","volume":"33","author":"Shapiro","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2022.110622_bib67","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1074\/jbc.M310815200","article-title":"Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library","volume":"279","author":"Shiraishi","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2022.110622_bib68","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s13071-014-0596-1","article-title":"The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India","volume":"7","author":"Singh","year":"2014","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.celrep.2022.110622_bib69","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.3390\/ijms20246197","article-title":"Gain-of-Function mutant p53: all the roads lead to tumorigenesis","volume":"20","author":"Stein","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2022.110622_bib70","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/onc.2014.359","article-title":"Functional interplay between MDM2, p63\/p73 and mutant p53","volume":"34","author":"Stindt","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2022.110622_bib71","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1021\/jm401753e","article-title":"Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development","volume":"57","author":"Sun","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.celrep.2022.110622_bib72","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJMsb1607705","article-title":"Limits to personalized cancer medicine","volume":"375","author":"Tannock","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2022.110622_bib73","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-12-2807","article-title":"MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models","volume":"73","author":"Tovar","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2022.110622_bib74","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1107\/S0907444904023510","article-title":"REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use","volume":"60","author":"Vagin","year":"2004","journal-title":"Acta Crystallogr. Section D, Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2022.110622_bib75","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/EBC20170052","article-title":"Structure-based drug design: aiming for a perfect fit","volume":"61","author":"van Montfort","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.celrep.2022.110622_bib76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.110622_bib77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng."},{"key":"10.1016\/j.celrep.2022.110622_bib78","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.onc.1204316","article-title":"The 'wildtype' conformation of p53: epitope mapping using hybrid proteins","volume":"20","author":"Wang","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2022.110622_bib79","first-page":"1466","article-title":"STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer","volume":"11","author":"Wang","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.celrep.2022.110622_bib80","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/ncomms2361","article-title":"Computational identification of a transiently open L1\/S3 pocket for reactivation of mutant p53","volume":"4","author":"Wassman","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110622_bib81","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: more and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci. a Publ. Protein Soc."},{"key":"10.1016\/j.celrep.2022.110622_bib82","doi-asserted-by":"crossref","first-page":"100688","DOI":"10.1016\/j.xpro.2021.100688","article-title":"Three optimized assays for the evaluation of compounds that can rescue p53 mutants","volume":"2","author":"Wu","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.celrep.2022.110622_bib83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/jmcb\/mjab007","article-title":"Broad-spectrum rescue compounds for structural p53 mutations: perspective on 'Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site'","volume":"13","author":"Wu","year":"2021","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2022.110622_bib84","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1039\/c9mt00102f","article-title":"Integrity of zinc finger motifs in PML protein is necessary for inducing its degradation by antimony","volume":"11","author":"Yang","year":"2019","journal-title":"Metallomics"},{"key":"10.1016\/j.celrep.2022.110622_bib85","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41467-021-21024-7","article-title":"Physical networks from entropy-driven non-covalent interactions","volume":"12","author":"Yu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.110622_bib86","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ccr.2012.03.042","article-title":"Allele-specific p53 mutant reactivation","volume":"21","author":"Yu","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2022.110622_bib87","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0091270009347674","article-title":"Clinical efficacy and pharmacokinetics of antimony in cutaneous leishmaniasis patients treated with sodium stibogluconate","volume":"50","author":"Zaghloul","year":"2010","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.celrep.2022.110622_bib88","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41419-018-0463-7","article-title":"APR-246 reactivates mutant p53 by targeting cysteines 124 and 277","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2022.110622_bib89","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/j.1460-2075.1994.tb06543.x","article-title":"A temperature-sensitive mutant of human p53","volume":"13","author":"Zhang","year":"1994","journal-title":"EMBO J."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722003709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722003709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:36:20Z","timestamp":1761910580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722003709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2211124722003709"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.110622","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing antiparasitic antimonials to noncovalently rescue temperature-sensitive p53 mutations","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.110622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"110622"}}